The flow cytometry data and Hoechst 33258 indicated that the silencing of RTKN2 resulted in notable induction of apoptosis, which was in keeping with previous studies on hepatocellular carcinoma [27], bladder cancer [28], leukemic [29], and colon cancer [19]. Here, RTKN2 is linked to urinary bladder carcinoma.